Pharmaceutical Business review

Affymetrix reports Q2 losses

While the net loss reported in the second quarter of 2008 includes a pretax restructuring charge of $0.9 million or $0.01 per diluted share, the net income posted in the corresponding period of 2007 included a pretax restructuring charge of $1.8 million or $0.03 per diluted share.

The company has reported total revenue of $86.9 million for the second quarter of 2008, compared to total revenue of $88.3 million for the corresponding period of 2007.

Product revenue was $75 million, which consists of array and reagent revenue of $68.9 million and instrument revenue of $6.1 million. Service revenue was $9 million, and royalties and other revenue were $2.9 million for the second quarter of 2008. This compares to second quarter 2007 product revenue of $68.4 million. Service revenue was $12 million, and royalties and other revenue were $7.9 million for the second quarter of 2007.